RF Acquisition Corp II /
Nanyang Biologics Pte.
RF Acquisition Corp II agrees to combine with Nanyang Biologics
Source for the buyer and target: RF Acquisition Corp II
For the buyer and target.
“This Business Combination Agreement, dated as of October 2, 2025 (this “ Agreement ”), is made and entered into by and among RF Acquisition Corp II, a Cayman Islands exempted company with limited liability (“ Acquiror ”), NYB Holdings Limited, a Cayman Islands exempted company with limited liability (“ PubCo ”), NYB Pte Ltd., a Singapore private company limited by shares and a direct wholly-owned Subsidiary of PubCo, with company registration number 202542481D (“ Amalgamation Sub ”) and Nanyang Biologics Pte.”
Published 2 Oct 2025
Open the sourceWhat happened
RF Acquisition Corp II entered into a Business Combination Agreement with NYB Holdings Limited, NYB Pte. Ltd. and Nanyang Biologics Pte. Ltd. The agreement provides for RF Acquisition Corp II to merge into NYB Holdings Limited, followed by the amalgamation of NYB Pte. Ltd. and Nanyang Biologics Pte. Ltd. [01]
Nanyang Biologics Pte. Ltd. will be the surviving company in the amalgamation and become a wholly owned subsidiary of NYB Holdings Limited. Terms weren't disclosed. [01]
The source
Everything on this page comes from the source below, quoted word for word.
RF Acquisition Corp II agrees to combine with Nanyang Biologics
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly